46.101.77.196
dgid:
enl:
npi:0
-Advertisement-
-Advertisement-
Retina
RGX-314 gene therapy shows promise in treating wet AMD in Phase 1/2a study
Machine learning shows promise in estimating tear osmolarity for contact lens wearers
Interventional Glaucoma and The Unmet Need of Stand Alone Patients
Astellas receives permanent J-code for avacincaptad pegol for geographic atrophy
Insights into Retinitis Pigmentosa: A Case Study with Maria Sampalis, OD
-Advertisement-
-Advertisement-

Polls & Quizzes

Quiz: Advancements in Glaucoma Surgery
Jan 17, 2024

Podcast Series

Interventional Glaucoma and The Unmet Need of Stand Alone Patients
Mar 27, 2024

Quizzes

Quiz: Advancements in Glaucoma Surgery
Jan 17, 2024

Videos

Insights into Retinitis Pigmentosa: A Case Study with Maria Sampalis, OD
Mar 27, 2024
Ocular Surface Disease
-Advertisement-
-Advertisement-
-Advertisement-
Geographic Atrophy

Iveric Bio, An Astellas Company, announced the U.S. Centers for Medicare and Medicaid Services (CMS) has assigned a unique, permanent Healthcare Common Procedure Coding System (HCPS) J-code for IZERVAY (avacincaptad pegol intravitreal solution)...

-Advertisement-
-Advertisement-
-Advertisement-
Oculoplastics
-Advertisement-
-Advertisement-
-Advertisement-